Article Text
Therapeutics
Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthma
Statistics from Altmetric.com
Footnotes
-
Sources of funding: Genentech, Inc. and Novartis Pharmaceuticals Corporation.
-
For correspondence: Dr H Milgrom, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA. milgromh{at}njc.org
↵† Information provided by author.